Kaposi's sarcoma (KS) is a multifocal tumor characterized by proliferating spindle cells of endothelial cell origin, erythrocyte-filled neovascular slits and an inflammatory cell infiltrate. KS is the most frequent cancer arising in HIV-infected individuals and is one of the most common neoplasms of children in developing countries. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) is the etiologic agent of KS, and drives tumor development via direct infection of lesional endothelial and spindle cells. Dermal microvascular endothelial cells (DMVEC) infected with KSHV in vitro harbor a primarily latent infection with a fraction of cells expressing lytic viral genes, a pattern that reflects viral gene expression patterns in vivo. KSHV-infected DMVEC develop a spindle morphology and a transformed phenotype and cellular gene expression profiling reveals viral induction of a number of potentially tumorigenic genes. One of these genes, the proto-oncogene c-Kit, was shown to play an essential role in DMVEC transformation in vitro and a preliminary analysis of KS tissue confirmed expression of c-Kit in KS tumors in vivo. The long-term goals of this project are to clarify the scope and temporal kinetics of c-Kit expression in KS tumors, and to clarify the viral and cellular mechanisms that lead to c-Kit expression and c-Kit-mediated cellular transformation.
Specific Aim 1 will use immunohistochemical and RT-PCR analysis to evaluate c-Kit expression in KS tumor tissue at early (patch and plaque) through late (nodular) stages of development in conjunction with serologic detection of latent or lytic KSHV infection.
Specific Aim 2 will use in vitro-infected DMVEC to identify the KSHV gene(s) responsible for c-Kit induction, and the molecular mechanisms involved.
Specific Aim 3 will use in vitro-infected DMVEC to elucidate downstream signaling pathways activated by c-Kit that lead ultimately to KSHV-induced transformation.
For Aims 2 and 3, adenovirus vectors will be used to overexpress viral and cellular genes of interest. Gene function will be validated with antisense oligonucleotides or pharmacologic inhibitors and appropriate functional assays, c-Kit has proven to be an effective therapeutic target for treatment of gastrointestinal stromal tumor (GIST). Clarification of the role of c-Kit in KSHV-associated endothelial transformation may suggest a similar approach for treatment of KS.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
Schools of Medicine
United States
Zip Code
Botto, Sara; Totonchy, Jennifer E; Gustin, Jean K et al. (2015) Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms. MBio 6:e00668
Totonchy, Jennifer E; Clepper, Lisa; Phillips, Kevin G et al. (2014) CXCR7 expression disrupts endothelial cell homeostasis and causes ligand-dependent invasion. Cell Adh Migr 8:165-76
Totonchy, Jennifer E; Osborn, Jessica M; Botto, Sara et al. (2013) Aberrant proliferation in CXCR7+ endothelial cells via degradation of the retinoblastoma protein. PLoS One 8:e69828
Sugaya, Makoto; Reed, Stacy; Rose, Patrick P et al. (2011) Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21. J Dermatol Sci 61:139-42
Douglas, Janet L; Gustin, Jean K; Moses, Ashlee V et al. (2010) Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation. Transl Biomed 1:
Douglas, Janet L; Whitford, Jill G; Moses, Ashlee V (2009) Characterization of c-Kit expression and activation in KSHV-infected endothelial cells. Virology 390:174-85
Mansouri, Mandana; Rose, Patrick P; Moses, Ashlee V et al. (2008) Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J Virol 82:9615-28
Rose, P P; Carroll, J M; Carroll, P A et al. (2007) The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma. Oncogene 26:1995-2005
Rose, Patrick P; Bogyo, Matthew; Moses, Ashlee V et al. (2007) Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. J Virol 81:8050-62
Mansouri, Mandana; Douglas, Janet; Rose, Patrick P et al. (2006) Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108:1932-40

Showing the most recent 10 out of 11 publications